Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GMCL1 pseudogene 2 (GMCL1P2) is classified as a pseudogene, specifically a non-coding homolog of the germ cell-less, spermatogenesis associated 1 gene (GMCL1), and is not known to encode a protein or act as a direct therapeutic target. Unlike the functional GMCL1 gene, which codes for a nuclear envelope protein involved in spermatogenesis and may have roles in the regulation of mitotic progression and taxane resistance in cancer, GMCL1P2 does not have a known molecular function, is not implicated in human disease as a causative agent, and does not interact with drugs or serve as a biomarker[3][5]. The entry "GMCL1P2" is often confused with "GMCL1," which is a functional gene and potential target, but "GMCL1P2" itself is a pseudogene and generally does not meet criteria as a protein-coding therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GMCL1 pseudogene 2 (GMCL1P2).